FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386410185> ?p ?o ?g. }

• W4386410185 abstract "Introduction Despite advances in the treatment of bipolar disorder (BD), most patients do not achieve complete inter-episode recovery and functional disability is common. During periods of relative remission, many patients continue to experience neurocognitive dysfunction, reduced daytime activity levels, and sleep disturbances. This 8-week, randomized, placebo-controlled pilot study evaluated the feasibility, safety and preliminary efficacy of the wake-promoting drug, modafinil (Provigil ® ), on neurocognitive functioning, daytime sleepiness, and sleep quality in affectively-stable BD patients. Methods Twelve individuals with affectively-stable BD were recruited and randomized to a flexible dose of modafinil (100 to 200 mg/day) or placebo, adjunctive to a therapeutic dose of a mood stabilizer. Weekly in-person visits tracked sleep quality and daytime sleepiness as well as side effects and mood symptoms. Neurocognitive functioning was assessed at baseline, week 4, and week 8. Results No serious adverse events were reported. Newly emergent side effects in the modafinil group included heart palpitations, itching, fatigue, and decreased energy. Two patients discontinued modafinil owing to side effects and one of these patients withdrew from the study. One patient discontinued placebo and was withdrawn from the study. Preliminary evaluations of clinical efficacy showed a marginally significant interaction between treatment group and time in two cognitive domains (speed of processing and verbal learning), indicating greater improvement in the modafinil group versus placebo. Additionally, there was a marginally significant effect of treatment group on daytime sleepiness, suggesting lower daytime sleepiness in the modafinil group versus placebo. Counterintuitively, we found a significant treatment group by time interaction effect on sleep quality, suggesting greater improvement in sleep quality in the placebo group versus the modafinil group. Discussion Results suggest that modafinil is a relatively safe medication for affectively-stable BD patients when given with adjunctive mood stabilizers. Results are suggestive of cognitive benefit and improved daytime sleepiness, but worse sleep quality in those patients prescribed modafinil. A fully powered clinical trial is warranted with specific attention to the characteristics of patients who are most likely to benefit from treatment with modafinil and other methodological lessons learned from this pilot. Clinical trial registration ClinicalTrials.gov , identifier NCT01965925." @default.
• W4386410185 created "2023-09-05" @default.
• W4386410185 creator A5016250393 @default.
• W4386410185 creator A5018953218 @default.
• W4386410185 creator A5020194880 @default.
• W4386410185 creator A5023616587 @default.
• W4386410185 creator A5054757667 @default.
• W4386410185 creator A5064854485 @default.
• W4386410185 creator A5081001975 @default.
• W4386410185 creator A5081806472 @default.
• W4386410185 date "2023-09-04" @default.
• W4386410185 modified "2023-09-28" @default.
• W4386410185 title "Modafinil’s effects on cognition and sleep quality in affectively-stable patients with bipolar disorder: a pilot study" @default.
• W4386410185 cites W197066864 @default.
• W4386410185 cites W1971141494 @default.
• W4386410185 cites W1982752781 @default.
• W4386410185 cites W1986998339 @default.
• W4386410185 cites W1988564186 @default.
• W4386410185 cites W1989320794 @default.
• W4386410185 cites W1997642725 @default.
• W4386410185 cites W2016130951 @default.
• W4386410185 cites W2016843706 @default.
• W4386410185 cites W2023634568 @default.
• W4386410185 cites W2024344981 @default.
• W4386410185 cites W2061378977 @default.
• W4386410185 cites W2064418720 @default.
• W4386410185 cites W2084151035 @default.
• W4386410185 cites W2087285273 @default.
• W4386410185 cites W2093849511 @default.
• W4386410185 cites W2094183880 @default.
• W4386410185 cites W2094459865 @default.
• W4386410185 cites W2104068787 @default.
• W4386410185 cites W2105454368 @default.
• W4386410185 cites W2110822505 @default.
• W4386410185 cites W2119981100 @default.
• W4386410185 cites W2122011624 @default.
• W4386410185 cites W2124270063 @default.
• W4386410185 cites W2126093392 @default.
• W4386410185 cites W2138482980 @default.
• W4386410185 cites W2148083007 @default.
• W4386410185 cites W2151487996 @default.
• W4386410185 cites W2161282771 @default.
• W4386410185 cites W2165955750 @default.
• W4386410185 cites W2561091445 @default.
• W4386410185 cites W2790303747 @default.
• W4386410185 cites W2981531343 @default.
• W4386410185 cites W4240718682 @default.
• W4386410185 doi "https://doi.org/10.3389/fpsyt.2023.1246149" @default.
• W4386410185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37732080" @default.
• W4386410185 hasPublicationYear "2023" @default.
• W4386410185 type Work @default.
• W4386410185 citedByCount "0" @default.
• W4386410185 crossrefType "journal-article" @default.
• W4386410185 hasAuthorship W4386410185A5016250393 @default.
• W4386410185 hasAuthorship W4386410185A5018953218 @default.
• W4386410185 hasAuthorship W4386410185A5020194880 @default.
• W4386410185 hasAuthorship W4386410185A5023616587 @default.
• W4386410185 hasAuthorship W4386410185A5054757667 @default.
• W4386410185 hasAuthorship W4386410185A5064854485 @default.
• W4386410185 hasAuthorship W4386410185A5081001975 @default.
• W4386410185 hasAuthorship W4386410185A5081806472 @default.
• W4386410185 hasBestOaLocation W43864101851 @default.
• W4386410185 hasConcept C118552586 @default.
• W4386410185 hasConcept C126322002 @default.
• W4386410185 hasConcept C142724271 @default.
• W4386410185 hasConcept C1513209611 @default.
• W4386410185 hasConcept C15744967 @default.
• W4386410185 hasConcept C168563851 @default.
• W4386410185 hasConcept C169900460 @default.
• W4386410185 hasConcept C172467417 @default.
• W4386410185 hasConcept C197934379 @default.
• W4386410185 hasConcept C204787440 @default.
• W4386410185 hasConcept C27081682 @default.
• W4386410185 hasConcept C2780714222 @default.
• W4386410185 hasConcept C2780733359 @default.
• W4386410185 hasConcept C2781433485 @default.
• W4386410185 hasConcept C42219234 @default.
• W4386410185 hasConcept C71924100 @default.
• W4386410185 hasConceptScore W4386410185C118552586 @default.
• W4386410185 hasConceptScore W4386410185C126322002 @default.
• W4386410185 hasConceptScore W4386410185C142724271 @default.
• W4386410185 hasConceptScore W4386410185C1513209611 @default.
• W4386410185 hasConceptScore W4386410185C15744967 @default.
• W4386410185 hasConceptScore W4386410185C168563851 @default.
• W4386410185 hasConceptScore W4386410185C169900460 @default.
• W4386410185 hasConceptScore W4386410185C172467417 @default.
• W4386410185 hasConceptScore W4386410185C197934379 @default.
• W4386410185 hasConceptScore W4386410185C204787440 @default.
• W4386410185 hasConceptScore W4386410185C27081682 @default.
• W4386410185 hasConceptScore W4386410185C2780714222 @default.
• W4386410185 hasConceptScore W4386410185C2780733359 @default.
• W4386410185 hasConceptScore W4386410185C2781433485 @default.
• W4386410185 hasConceptScore W4386410185C42219234 @default.
• W4386410185 hasConceptScore W4386410185C71924100 @default.
• W4386410185 hasFunder F4320337346 @default.
• W4386410185 hasLocation W43864101851 @default.
• W4386410185 hasLocation W43864101852 @default.
• W4386410185 hasOpenAccess W4386410185 @default.
• W4386410185 hasPrimaryLocation W43864101851 @default.
• W4386410185 hasRelatedWork W2020702147 @default.

• next